A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001)

被引：4

作者：

Yildirim, Halil Cumhur ^{[1
]}

Kupik, Gulnihan Eren ^{[2
]}

Mustafayev, Teuta Zoto ^{[3
]}

Berber, Tanju ^{[4
]}

Yavuz, Berrin ^{[5
]}

Cetinayak, Oguz ^{[6
]}

Akagunduz, Ozlem ^{[7
]}

Bicakci, Beyhan Ceylaner ^{[8
]}

Arslan, Suheyla Aytac ^{[9
]}

Soykut, Ela Delikgoz ^{[10
]}

Gundog, Mete ^{[11
]}

Figen, Metin ^{[12
]}

Teke, Fatma ^{[13
]}

Canyilmaz, Emine ^{[14
]}

Birgi, Sumerya Duru ^{[15
]}

Duzova, Mursel ^{[16
]}

Igdem, Sefik ^{[17
]}

Abakay, Candan Demiroz ^{[18
]}

Atasoy, Beste ^{[19
]}

Kaydihan, Nuri ^{[20
]}

Parvizi, Murtaza ^{[21
]}

Uslu, Gonca Hanedan ^{[22
]}

Saginc, Halil ^{[23
]}

Akman, Fadime ^{[6
]}

Ozyar, Enis ^{[3
]}

机构：

[1] Istanbul Univ Cerrahpasa, Cerrahpasa Fac Med, Dept Radiat Oncol, Istanbul, Turkiye

[2] Mugla Sitki Kocman Univ, Fac Med, Dept Radiat Oncol, Mugla, Turkiye

[3] Acibadem Univ, Fac Med, Dept Radiat Oncol, Istanbul, Turkiye

[4] Prof Dr Cemil Tascioglu City Hosp, Dept Radiat Oncol, Istanbul, Turkiye

[5] Necmettin Erbakan Univ, Meram Fac Med, Dept Radiat Oncol, Konya, Turkiye

[6] Dokuz Eylul Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkiye

[7] Ege Univ, Fac Med, Dept Radiat Oncol, Izmir, Turkiye

[8] Kartal Dr Lutfi Kirdar City Hosp, Dept Radiat Oncol, Istanbul, Turkiye

[9] Ankara City Hosp, Dept Radiat Oncol, Ankara, Turkiye

[10] Samsun Educ & Res Hosp, Dept Radiat Oncol, Samsun, Turkiye

[11] Erciyes Univ, Fac Med, Dept Radiat Oncol, Kayseri, Turkiye

[12] Sisli Hamidiye Etfal Educ & Res Hosp, Dept Radiat Oncol, Istanbul, Turkiye

[13] Dicle Univ, Fac Med, Dept Radiat Oncol, Diyarbakir, Turkiye

[14] Karadeniz Tech Univ, Fac Med, Dept Radiat Oncol, Trabzon, Turkiye

[15] Ankara Univ, Fac Med, Dept Radiat Oncol, Ankara, Turkiye

[16] Selcuk Univ, Fac Med, Dept Radiat Oncol, Konya, Turkiye

[17] Istanbul Bilim Univ, Gayrettepe Florence Nightingale Hosp, Dept Radiat Oncol, Istanbul, Turkiye

[18] Bursa Uludag Univ, Fac Med, Dept Radiat Oncol, Bursa, Turkiye

[19] Marmara Univ, Fac Med, Dept Radiat Oncol, Istanbul, Turkiye

[20] Istanbul Bahcelievler Mem Hosp, Dept Radiat Oncol, Istanbul, Turkiye

[21] Manisa City Hosp, Dept Radiat Oncol, Manisa, Turkiye

[22] Trabzon Kanuni Educ & Res Hosp, Dept Radiat Oncol, Trabzon, Turkiye

[23] Pamukkale Univ, Fac Med, Dept Radiat Oncol, Denizli, Turkiye

来源：

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2023年 / 45卷 / 05期

关键词：

chemoradiotherapy; EBV-DNA; intensity-modulated radiotherapy; nasopharyngeal carcinoma; nonendemic; INTENSITY-MODULATED RADIOTHERAPY; AJCC/UICC STAGING SYSTEM; CONCURRENT CHEMORADIOTHERAPY; 8TH EDITION; CHEMOTHERAPY; DNA; VALIDATION; OUTCOMES; TRIALS; AREAS;

D O I：

10.1002/hed.27333

中图分类号：

R76 [耳鼻咽喉科学];

学科分类号：

100213 ;

摘要：

BackgroundWe aimed to evaluate patients with nasopharyngeal carcinoma (NPC) in a nonendemic population. MethodsIn a national, retrospective, multicenteric study, 563 patients treated with intensity modulated radiotherapy at 22 centers between 2015 and 2020 were analyzed. ResultsMedian age was 48 (9-83), age distribution was bimodal, 74.1% were male, and 78.7% were stage III-IVA. Keratinizing and undifferentiated carcinoma rates were 3.9% and 81.2%. Patients were treated with concomitant chemoradiotherapy (48.9%), or radiotherapy combined with induction chemotherapy (25%) or adjuvant chemotherapy (19.5%). After 34 (6-78) months follow-up, 8.2% locoregional and 8% distant relapse were observed. Three-year overall survival was 89.5% and was lower in patients with age >= 50, male sex, keratinizing histology, T4, N3 and advanced stage (III-IVA). ConclusionsPatients with NPC in Turkey have mixed clinical features of both east and west. Survival outcomes are comparable to other reported series; however, the rate of distant metastases seems to be lower.

引用

页码：1194 / 1205

页数：12

共 38 条

[31] Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial [J].

Sun, Ying ;

Li, Wen-Fei ;

Chen, Nian-Yong ;

Zhang, Ning ;

Hu, Guo-Qing ;

Xie, Fang-Yun ;

Sun, Yan ;

Chen, Xiao-Zhong ;

Li, Jin-Gao ;

Zhu, Xiao-Dong ;

Hu, Chao-Su ;

Xu, Xiang-Ying ;

Chen, Yuan-Yuan ;

Hu, Wei-Han ;

Guo, Ling ;

Mo, Hao-Yuan ;

Chen, Lei ;

Mao, Yan-Ping ;

Sun, Rui ;

Ai, Ping ;

Liang, Shao-Bo ;

Long, Guo-Xian ;

Zheng, Bao-Min ;

Feng, Xing-Lai ;

Gong, Xiao-Chang ;

Li, Ling ;

Shen, Chun-Ying ;

Xu, Jian-Yu ;

Guo, Ying ;

Chen, Yu-Ming ;

Zhang, Fan ;

Lin, Li ;

Tang, Ling-Long ;

Liu, Meng-Zhong ;

Ma, Jun .

LANCET ONCOLOGY, 2016, 17 (11) :1509-1520

[32] Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].

Sung, Hyuna ;

Ferlay, Jacques ;

Siegel, Rebecca L. ;

Laversanne, Mathieu ;

Soerjomataram, Isabelle ;

Jemal, Ahmedin ;

Bray, Freddie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249

[33] Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era [J].

Tang, Ling-Long ;

Chen, Yu-Pei ;

Mao, Yan-Ping ;

Wang, Zi-Xian ;

Guo, Rui ;

Chen, Lei ;

Tian, Li ;

Lin, Ai-Hua ;

Li, Li ;

Sun, Ying ;

Ma, Jun .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (07) :913-919

[34] Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up [J].

Wu, Li-Rong ;

Zhang, Xiu-Ming ;

Xie, Xiao-Dong ;

Lu, Yue ;

Wu, Jian-Feng ;

He, Xia .

ORAL ONCOLOGY, 2019, 98 :141-146

[35] Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study [J].

Xu, Man ;

Zang, Jian ;

Luo, Shanquan ;

Wang, Jianhua ;

Li, Xuqi .

BMJ OPEN, 2021, 11 (08)

[36] Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma [J].

Zhang, Yuan ;

Chen, Lei ;

Hu, Guo-Qing ;

Zhang, Ning ;

Zhu, Xiao-Dong ;

Yang, Kun-Yu ;

Jin, Feng ;

Shi, Mei ;

Chen, Yu-Pei ;

Hu, Wei-Han ;

Cheng, Zhi-Bin ;

Wang, Si-Yang ;

Tian, Ye ;

Wang, Xi-Cheng ;

Sun, Yan ;

Li, Jin-Gao ;

Li, Wen-Fei ;

Li, Yu-Hong ;

Tang, Ling-Long ;

Mao, Yan-Ping ;

Zhou, Guan-Qun ;

Sun, Rui ;

Liu, Xu ;

Guo, Rui ;

Long, Guo-Xian ;

Liang, Shao-Qiang ;

Li, Ling ;

Huang, Jing ;

Long, Jin-Hua ;

Zang, Jian ;

Liu, Qiao-Dan ;

Zou, Li ;

Su, Qiong-Fei ;

Zheng, Bao-Min ;

Xiao, Yun ;

Guo, Ying ;

Han, Fei ;

Mo, Hao-Yuan ;

Lv, Jia-Wei ;

Du, Xiao-Jing ;

Xu, Cheng ;

Liu, Na ;

Li, Ying-Qin ;

Chua, Melvin L. K. ;

Xie, Fang-Yun ;

Sun, Ying ;

Ma, Jun .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (12) :1124-1135

[37] Clinical outcome for nasopharyngeal carcinoma with predominantly WHO II histology treated with intensity-modulated radiation therapy in non-endemic region of China [J].

Zhao, Li-Na ;

Zhou, Bin ;

Shi, Mei ;

Wang, Jian-Hua ;

Xiao, Feng ;

Xu, Man ;

Luo, Shan-Quan ;

Xue, Ying ;

Li, Jian-Ping ;

Tan, Li-Na .

ORAL ONCOLOGY, 2012, 48 (09) :864-869

[38]

Zoto Mustafayev Teuta, 2017, Int J Radiat Oncol Biol Phys, V99, P1306, DOI 10.1016/j.ijrobp.2017.08.034

← 1 2 3 4 →